| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $802.8M | +28.5% |
| Cost of Revenue | $123.0M | +27.3% |
| Gross Profit | $679.8M | +28.7% |
| R&D Expense | $114.1M | -2.1% |
| SG&A Expense | $529.6M | +17.2% |
| Operating Income | $36.1M | +189.6% |
| Pre-tax Income | $58.5M | +393.6% |
| Income Tax | $4.9M | +296.5% |
| Net Income | $53.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $150.2M | -19.1% |
| Short-term Investments | $295.4M | +7.5% |
| Accounts Receivable | $93.1M | +3.5% |
| Inventory | $80.1M | +136.4% |
| Current Assets | $630.8M | +6.2% |
| Total Assets | $808.4M | +19.4% |
| Current Liabilities | $88.5M | +13.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $130.2M | +428.3% |
| Capital Expenditures | $39.1M | +65.6% |
| Investing Cash Flow | -$113.1M | +61.6% |
| Financing Cash Flow | -$52.4M | -475.6% |
| Free Cash Flow | $91.1M | +8798.7% |
| +353.0% |
| EPS (Basic) | $1.80 | +350.0% |
| EPS (Diluted) | $1.75 | +343.1% |
| Total Liabilities |
| $118.7M |
| +13.8% |
| Stockholders' Equity | $689.7M | +20.5% |